Antti Kaipia

Medicine & Life Sciences

1. Allopurinol 28%
2. Biopsy 13%
3. Cancer Survivors 24%
4. Catheters 17%
5. Chronic Pain 20%
6. Cohort Studies 16%
7. Cross-Sectional Studies 15%
8. Delivery of Health Care 16%
9. Emotions 17%
10. Erectile Dysfunction 23%
11. Finland 100%
12. Health Care Outcome Assessment 7%
13. Hyperuricemia 27%
14. Incidence 25%
15. Infections 21%
16. Interviews 12%
17. LH Receptors 30%
18. Luteinizing Hormone 10%
19. Mortality 22%
20. Multicenter Studies 21%
21. National Institutes of Health (U.S.) 14%
22. Neoplasms 10%
23. Orthopedic Procedures 12%
24. Pain 9%
25. Patient Education 28%
26. Pelvic Pain 26%
27. Penile Neoplasms 95%
28. Penis 25%
29. Population 11%
30. Postoperative Complications 42%
31. Professional Education 7%
32. Prospective Studies 16%
33. Prostate 13%
34. Prostate-Specific Antigen 19%
35. Prostatectomy 68%
36. Prostatic Neoplasms 62%
37. Prostatitis 28%
38. Quality of Health Care 19%
39. Randomized Controlled Trials 15%
40. Registries 15%
41. Shared Decision Making 27%
42. Social Support 21%
43. Survival 12%
44. Testicular Neoplasms 25%
45. Therapeutics 17%
46. Transcranial Magnetic Stimulation 25%
47. Uric Acid 12%
48. Urinary Bladder Neoplasms 12%
49. Urinary Catheters 9%
50. Visual Analog Scale 20%